RenovoRx Inc expected to post a loss of 7 cents a share - Earnings Preview

RenovoRx

10/08/2026 22:06

RenovoRx Inc RNXT.OQ RNXT.O is expected to  show a rise in quarterly revenue when it reports  results on August 12 for the period ending June 30 2026
The Mountain View California-based  company is expected to report a 69.8% increase in revenue to $716.5 thousand from $422 thousand a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
​LSEG's mean analyst estimate for RenovoRx Inc is for a loss of 7 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for RenovoRx Inc is $5.50, about 391.1% above its last closing price of $1.12
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.08
-0.08
-0.09
Missed
-12.5
Dec. 31 2026
-0.08
-0.08
-0.08
Met
0
Sep. 30 2025
-0.08
-0.08
Met
0​
Jun. 30 2025
-0.09
-0.08
-0.08
Met
5.9
​​Mar. 31 2025
-0.08
-0.08
-0.08
Met
0
Dec. 31 2024
-0.12
-0.11
-0.13
Missed
-18.2​
Sep. 30 2024
-0.12
-0.12
-0.10
Beat
16.7
Jun. 30 2024
-0.10
-0.10
-0.10
Met
0
This summary was machine generated August 10 at 21:06 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)